共 45 条
[1]
Aguwa C.C., Monplaisire L., Sylajakumari P.A., Rules modification on a fuzzy based modular architecture for medical device design and development, IIE Trans Healthc Syst Eng, 2, 1, pp. 50-61, (2012)
[2]
Alawamleh M., Popplewell K., Interpretive structural modelling of risk sources in a virtual organisation, Int J Prod Res, 49, 20, pp. 6041-6063, (2011)
[3]
Attri R., Grover S., Dev N., Kumar D., An ISM approach for modelling the enablers in the implementation of total productive maintenance (TPM), Int J Syst Assur Eng Manag, 4, 4, pp. 313-326, (2013)
[4]
Attri R., Grover S., Dev N., Kumar D., Analysis of barriers of total productive maintenance (TPM), Int J Syst Assur Eng Manag, 4, 4, pp. 365-377, (2013)
[5]
Borade A., Bansod S., Interpretive structural modelling-based framework for VMI adoption in Indian industries, Int J Adv Manuf Technol, 58, 9-12, pp. 1227-1242, (2012)
[6]
Borcherding B., Exposing risk throughout your product development lifecycle: best practices for medical device development, Free white paper, (2013)
[7]
Braceras I., Ipinazar E., Maeztu M.A., Alava J.I., Risk analysis and implants, Med Eng Phys, 30, 9, pp. 1201-1204, (2008)
[8]
Chan S.L., Ip W.H., Zhang W.J., Integrating failure analysis and risk analysis with quality assurance in the design phase of medical device development, Int J Prod Res, 50, 8, pp. 2190-2203, (2012)
[9]
Chang A.Y., Hu K.J., Hong Y.L., An ISM–ANP approach to identifying key agile factors in launching a new product into mass production, Int J Prod Res, 51, 2, pp. 582-597, (2013)
[10]
Cheng S., Das D., Pecht M., Using failure modes, mechanisms, and effects analysis in medical device adverse event investigations, In: Paper presented at international conference on biomedical ontology Buffalo, (2011)